Welcome to LookChem.com Sign In|Join Free

CAS

  • or

85819-04-1

2-(2-methoxy-4-nitrophenoxy)acetic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

85819-04-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 85819-04-1 Structure

  • Basic information

    1. Product Name: 2-(2-methoxy-4-nitrophenoxy)acetic acid
    2. Synonyms: 2-(2-methoxy-4-nitrophenoxy)acetic acid
    3. CAS NO:85819-04-1
    4. Molecular Formula:
    5. Molecular Weight: 227.174
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 85819-04-1.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-(2-methoxy-4-nitrophenoxy)acetic acid(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-(2-methoxy-4-nitrophenoxy)acetic acid(85819-04-1)
    11. EPA Substance Registry System: 2-(2-methoxy-4-nitrophenoxy)acetic acid(85819-04-1)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 85819-04-1(Hazardous Substances Data)

85819-04-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 85819-04-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,5,8,1 and 9 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 85819-04:
(7*8)+(6*5)+(5*8)+(4*1)+(3*9)+(2*0)+(1*4)=161
161 % 10 = 1
So 85819-04-1 is a valid CAS Registry Number.

85819-04-1Downstream Products

85819-04-1Relevant articles and documents

Identification of highly potent BTK and JAK3 dual inhibitors with improved activity for the treatment of B-cell lymphoma

Ge, Yang,Wang, Changyuan,Song, Shijie,Huang, Jiaxin,Liu, Zhihao,Li, Yongming,Meng, Qiang,Zhang, Jianbin,Yao, Jihong,Liu, Kexin,Ma, Xiaodong,Sun, Xiuli

, p. 1847 - 1857 (2018)

The BTK and JAK3 receptor tyrosine kinases are two validated and therapeutically amenable targets in the treatment of B-cell lymphomas. Here we report the identification of several classes of pyrimidine derivatives as potent BTK and JAK3 dual inhibitors.

Potent human glutaminyl cyclase inhibitors as potential anti-Alzheimer's agents: Structure-activity relationship study of Arg-mimetic region

Ngo, Van T.H.,Hoang, Van-Hai,Tran, Phuong-Thao,Ann, Jihyae,Cui, Minghua,Park, Gyungseo,Choi, Sun,Lee, Jiyoun,Kim, Hee,Ha, Hee-Jin,Choi, Kwanghyun,Kim, Young-Ho,Lee, Jeewoo

, p. 1035 - 1049 (2018/02/12)

Pyroglutamate-modified amyloid β peptides (pGlu-Aβ) are highly neurotoxic and promote the formation of amyloid plaques. The pGlu-Aβ peptides are generated by glutaminyl cyclase (QC), and recent clinical studies indicate that QC represents an alternative t

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 85819-04-1